<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Geuka Africa | Erin Conroy | Activity</title>
	<link>https://geuka.org/members/erinconroy/activity/</link>
	<atom:link href="https://geuka.org/members/erinconroy/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Erin Conroy.</description>
	<lastBuildDate>Wed, 10 Jun 2026 08:40:23 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">5d9eeee2faf3a2055d78d14fa4f7b12d</guid>
				<title>Erin Conroy started the topic Understanding 5CLADBA: An Overview for Responsible Research in the forum Basic Home Budgeting</title>
				<link>https://geuka.org/forums/topic/understanding-5cladba-an-overview-for-responsible-research-6/</link>
				<pubDate>Thu, 04 Jun 2026 21:57:17 +0000</pubDate>

									<content:encoded><![CDATA[<p>Observation item 1st injection 2nd injection 3rd injection 4th injection 5th injection Con. All groups treated with tested synthetic cannabinoids showed decreased weight gain rate in a dose-dependent manner. A total of 5 mice in the JWH-081 (5 mg/kg, i.p.) treated group and 6 mice in the adb butinaca JWH-210 (5 mg/kg, i.p.) treated group showed&hellip;<span class="activity-read-more" id="activity-read-more-206691"><a href="https://geuka.org/forums/topic/understanding-5cladba-an-overview-for-responsible-research-6/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">47ecde5b17f56c43e916d13490fc509c</guid>
				<title>Erin Conroy started the topic Clinical features associated with ADB-BUTINACA exposure in patients attending. in the forum Basic Home Budgeting</title>
				<link>https://geuka.org/forums/topic/clinical-features-associated-with-adb-butinaca-exposure-in-patients-attending-12/</link>
				<pubDate>Thu, 04 Jun 2026 21:55:46 +0000</pubDate>

									<content:encoded><![CDATA[<p>4. Drugs<br />
The purpose of the present study was to assess the abuse liability of 5F-MDMB-PINACA, MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA. The findings produce an apparent paradox, since CPP and self-administration predict with high reliability the likelihood that a compound will be abused by humans, and cannabinoids are&hellip;<span class="activity-read-more" id="activity-read-more-206690"><a href="https://geuka.org/forums/topic/clinical-features-associated-with-adb-butinaca-exposure-in-patients-attending-12/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">1f10a23ada95d8f827aba0e45dc8dd2a</guid>
				<title>Erin Conroy started the topic JWH-210 CHEMICAL POWDER in the forum Basic Home Budgeting</title>
				<link>https://geuka.org/forums/topic/jwh-210-chemical-powder-10/</link>
				<pubDate>Thu, 04 Jun 2026 21:53:27 +0000</pubDate>

									<content:encoded><![CDATA[<p>Figure 1.<br />
Each training session lasted a maximum of 10 min, and the rats could earn up to 20 food pellets. Thirty minutes prior to the training sessions, rats received an injection of either vehicle or Δ9-THC and were subsequently placed in the behavior-testing chambers, where food (45-mg food pellets; Bio-Serve, Frenchtown, NJ) was available as&hellip;<span class="activity-read-more" id="activity-read-more-206688"><a href="https://geuka.org/forums/topic/jwh-210-chemical-powder-10/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">39b0ef98d7a17b8fe9cc84cc23068aee</guid>
				<title>Erin Conroy started the topic Understanding 5CLADBA: An Overview for Responsible Research in the forum Basic Home Budgeting</title>
				<link>https://geuka.org/forums/topic/understanding-5cladba-an-overview-for-responsible-research-2/</link>
				<pubDate>Tue, 26 May 2026 07:49:28 +0000</pubDate>

									<content:encoded><![CDATA[<p>Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. It is illegal to sell, distribute, supply, transport or trade the pharmaceutical drug under the Psychoactive Substances Act 2016. The corresponding indole core analogue, 4F-MDMB-BICA (4F-MDMB-BUTICA), has also&hellip;<span class="activity-read-more" id="activity-read-more-204436"><a href="https://geuka.org/forums/topic/understanding-5cladba-an-overview-for-responsible-research-2/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
		
	</channel>
</rss>